Cargando…
Preventing cardiac damage in patients with COVID-19
A cardiac organoid approach combined with phosphoproteomics and single nuclei RNA-sequencing identifies bromodomain and extraterminal family inhibitors as promising candidates to prevent COVID-19 mediated cardiac damage.
Autor principal: | Robson, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025058/ https://www.ncbi.nlm.nih.gov/pubmed/33828252 http://dx.doi.org/10.1038/s41569-021-00550-3 |
Ejemplares similares
-
Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020) -
Social disparities in COVID-19 prevention
por: Fitzpatrick, Ciarán Martin
Publicado: (2021) -
The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022) -
Reduced hospital admissions for ACS — more collateral damage from COVID-19
por: Huynh, Karina
Publicado: (2020) -
COVID-19 and Tuberculosis
por: Yang, Heng, et al.
Publicado: (2020)